SEC Form 4 · accession 0001235802-18-000032
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 28, 2018
Accepted (ET)
Mar 1, 2018 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1,F2 | Feb 28, 2018 | D | 3,156,732 | $24.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
- F2The securities are owned directly by Split Rock Partners, LP ("SRP"). Voting and investment power over the securities is delegated to Split Rock Partners Management, LLC ("SRPM"), the general partner of SRP. SRPM has delegated voting and investment decisions to Michael Gorman, James Simons and David Stassen (collectively, the "General Partner Designees"), who require a two-thirds vote to act. Each of the General Partner Designees disclaims beneficial ownership of the securities except to the extent of any pecuniary interest therein.